OneWorld Health Safety and Efficacy Study of Kala-Azar Treatment in Bangladesh Moves Forward
12/28/2011 7:04:43 AM
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--OneWorld Health (OWH), a non-profit organization dedicated to developing lifesaving medicines for neglected diseases in children, announced completion of enrollment for an effectiveness study of Paromomycin Intramuscular Injection (PMIM) as a treatment for visceral leishmaniasis (VL or kala-azar) in Bangladesh. With 120 patients enrolled, the study is investigating the safety and efficacy of treatment of kala-azar with PMIM mono-therapy in VL-endemic areas of the country.
comments powered by